Skip to main content
Top
Published in: Trials 1/2021

Open Access 01-12-2021 | Letter

Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial

Authors: Verena Keitel, Björn Jensen, Torsten Feldt, Johannes C. Fischer, Johannes G. Bode, Christiane Matuschek, Edwin Bölke, Wilfried Budach, Christian Plettenberg, Kathrin Scheckenbach, Detlef Kindgen-Milles, Jörg Timm, Lisa Müller, Henrike Kolbe, Andreas Stöhr, Christian Calles, Andreas Hippe, Pablo Verde, Christoph D. Spinner, Jochen Schneider, Timo Wolf, Winfried V. Kern, Jacob Nattermann, Alexander Zoufaly, Christian Ohmann, Tom Luedde, RES-Q-HR Trial Team

Published in: Trials | Issue 1/2021

Login to get access
Metadata
Title
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial
Authors
Verena Keitel
Björn Jensen
Torsten Feldt
Johannes C. Fischer
Johannes G. Bode
Christiane Matuschek
Edwin Bölke
Wilfried Budach
Christian Plettenberg
Kathrin Scheckenbach
Detlef Kindgen-Milles
Jörg Timm
Lisa Müller
Henrike Kolbe
Andreas Stöhr
Christian Calles
Andreas Hippe
Pablo Verde
Christoph D. Spinner
Jochen Schneider
Timo Wolf
Winfried V. Kern
Jacob Nattermann
Alexander Zoufaly
Christian Ohmann
Tom Luedde
RES-Q-HR Trial Team
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Trials / Issue 1/2021
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-021-05181-0

Other articles of this Issue 1/2021

Trials 1/2021 Go to the issue